AKZO NOBEL SPONS.ADRS 1/3 Financial Flexibility Index
AKZO NOBEL SPONS.ADRS 1/3 financial flexibility index. AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of €232.00 Million (operating CF €170.00 Million minus capex €62.00 Million) represents 0% of total liabilities (€11.10 Billion). See AKUP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
Financial flexibility index of AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025. Historical Financial Flexibility Index trend for AKZO NOBEL SPONS.ADRS 1/3 across 4 annual periods. Check AKUP cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
AKZO NOBEL SPONS.ADRS 1/3 Financial Flexibility Index by Year (2022–2025)
AKZO NOBEL SPONS.ADRS 1/3 financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for AKZO NOBEL SPONS.ADRS 1/3. For the full cash flow conversion analysis, see AKZO NOBEL SPONS.ADRS 1/3 operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | €1.22 Billion | €915.00 Million | €9.13 Billion | ▲ +29.2% |
| 2024 | 0.10x | €979.00 Million | €673.00 Million | €9.43 Billion | ▼ -26.4% |
| 2023 | 0.14x | €1.41 Billion | €1.13 Billion | €10.01 Billion | ▲ +159.0% |
| 2022 | 0.05x | €555.00 Million | €263.00 Million | €10.19 Billion | — |